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ABSTRACT
Background: Locoregional hyperthermia is applied to deep-seated tumours in the pelvic region. Two
very different heating techniques are often applied: capacitive and radiative heating. In this paper,
numerical simulations are applied to compare the performance of both techniques in heating of deep-
seated tumours.
Methods: Phantom simulations were performed for small (30 20 50 cm3) and large (45 30 50 cm3),
homogeneous fatless and inhomogeneous fat-muscle, tissue-equivalent phantoms with a central or
eccentric target region. Radiative heating was simulated with the 70MHz AMC-4 system and capaci-
tive heating was simulated at 13.56MHz. Simulations were performed for small fatless, small (i.e. fat
layer typically <2 cm) and large (i.e. fat layer typically >3 cm) patients with cervix, prostate, bladder
and rectum cancer. Temperature distributions were simulated using constant hyperthermic-level per-
fusion values with tissue constraints of 44 C and compared for both heating techniques.
Results: For the small homogeneous phantom, similar target heating was predicted with radiative and
capacitive heating. For the large homogeneous phantom, most effective target heating was predicted
with capacitive heating. For inhomogeneous phantoms, hot spots in the fat layer limit adequate cap-
acitive heating, and simulated target temperatures with radiative heating were 2–4 C higher. Patient
simulations predicted therapeutic target temperatures with capacitive heating for fatless patients, but
radiative heating was more robust for all tumour sites and patient sizes, yielding target temperatures
1–3 C higher than those predicted for capacitive heating.
Conclusion: Generally, radiative locoregional heating yields more favourable simulated temperature
distributions for deep-seated pelvic tumours, compared with capacitive heating. Therapeutic tempera-
tures are predicted for capacitive heating in patients with (almost) no fat.
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Introduction
Hyperthermia, i.e. heating of tumours to temperatures of
40–43 C for 1 h, is clinically applied to enhance the effective-
ness of radiotherapy and chemotherapy [1]. Locoregional
hyperthermia is applied to tumours located deeper than
4 cm beyond the skin. Clinical applications of locoregional
hyperthermia involve mainly pelvic tumours, such as pros-
tate, bladder, rectum and cervix/vagina [2–8].
The sensitisation by hyperthermia and thus the increase in
clinical outcome is determined by the achieved temperatures
in the target region [3,5,9]. A thermal dose–effect relationship
has been demonstrated in pre-clinical and clinical studies, so it
is important to aim for high tumour temperatures, with 43 C
being the widely accepted goal for tumour temperatures [10].
The heating technique used can have an impact on the
tumour temperatures that can be realised. Both capacitive
and electromagnetic radiative hyperthermia systems are
frequently used in clinical hyperthermia for deep-seated
tumours [2,3,5,11–15]. Capacitive systems were initially
mainly used in Asian countries, but popularity in the Western
world is increasing, since capacitive systems are more afford-
able and easier to use than radiative systems. Commercially
available capacitive systems operating at 13.56MHz are
Oncotherm (Oncotherm Kft, Budapest, Hungary), Celsius TCS
(Celsius42þGmbH, Cologne, Germany), HY-DEEP 600WM
(Andromedic srl, Velletri, Italy) and Synchrotherm
(Synchrotherm, Vigevano, Italy). The Thermotron RF8 system
(Yamamoto Vinita Co, Osaka, Japan) operates at 8MHz.
Capacitive heating applies electrodes with an integrated
water bolus bag. Additional boluses (overlay boluses) can be
used for more aggressive skin cooling [16]. The patient is typ-
ically lying on a treatment table with an embedded electrode
and integrated water bolus. Another electrode (with inte-
grated water bolus) is positioned on the patient and the
resulting currents produced by capacitive coupling with the
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human body cause heating. Synchrotherm and HY-DEEP
600WM apply two flexible electrodes that can be positioned
at any desired location on the patient. When equally sized
electrodes are used, the absorbed power is directed towards
the centre of the distance between the electrodes [17]. When
different sizes of electrodes are combined, the power distri-
bution is directed to the side of the smallest electrode [17].
Thus, for eccentric tumours the diameters are usually differ-
ent, with the smallest electrode closest to the tumour loca-
tion. Radiative external antennas induce an electromagnetic
field that is coupled into the patient using a water bolus.
Adequate target heating can be realised by using phase and
amplitude steering to create constructive interference among
the electromagnetic fields radiated by the individual anten-
nas [18–20]. Radiative heating systems typically operate in
the frequency range between 70 and 120MHz. Examples of
commercial radiative locoregional systems are the BSD-2000
systems (Pyrexar Medical, Salt Lake City, UT) [19,21] and the
ALBA 4D system (ALBA Hyperthermia, Rome, Italy). The latter
is similar to the 70MHz AMC-4 system, developed and built
by the Academic Medical Center Amsterdam [22].
The frequent clinical application of two distinctly different
heating techniques raises the question whether there are dif-
ferences in heating effectiveness between capacitive and
radiative systems that lead to clinically relevant differences in
heating quality for the general patient population. Evaluation
of such differences by analysis of clinical studies is very diffi-
cult since 3D temperature information during clinical hyper-
thermia is lacking. Additionally, there is an inter-patient
variation, which makes such an evaluation more complicated.
For example, there can be a significant difference in average
body dimensions of the patients in various clinical studies,
which makes it difficult to draw conclusions about the heat-
ing effectiveness of two different techniques. Performing
alternating treatment sessions with capacitive heating and
radiative heating would be an option [23], but in that case
institutes should have access to both types of equipment
and experienced staff for both techniques. This makes a fair
clinical comparison very difficult.
Therefore, a comparison of heating systems using theoret-
ical methods would be the answer [24]. Hyperthermia treat-
ment planning is a very useful method to analyse the
differences between different heating techniques, using
numerical simulation of 3D power and temperature distribu-
tions [25]. A clear advantage of a simulation study is also the
direct comparison, since all variables can be kept constant in
the model and only the heating system is varied. Kok et al.
demonstrated the use of hyperthermia treatment planning to
assess the impact of aperture size and operating frequency for
waveguide systems [20,26]. Paulsen et al. evaluated the effect
of the number of antennas and the operating frequency for
various target locations [18]. Wust et al. compared the heating
characteristics of the BSD Sigma-60 with four paired dipole
antennas with the BSD Sigma-Eye system with 12 paired
dipoles [19]. Some simulation studies have been published to
compare capacitive and radiative heating. Kok et al. compared
capacitive and radiative heating for superficial locations and
large extremity lesions [27–29], while Kroeze et al. evaluated
the differences for locoregional heating evaluating phantom
set-ups and a single patient anatomy [30]. However, a thor-
ough theoretical evaluation of differences in heating patterns
for locoregional hyperthermia with radiative and capacitive
systems is not provided by the previous studies. This requires
to evaluate the differences in heatability between different
target locations (central and eccentric) and different patient
dimensions by comparing simulated temperature distributions
for common pelvic tumours.
This study applied hyperthermia treatment planning to
analyse the differences in target heating between capacitive
and radiative locoregional hyperthermia for deep-seated
tumours. Simulations with both heating techniques were per-
formed for small and large fatless homogeneous and
inhomogeneous fat-muscle phantoms with a central or
eccentric target location, assuming constant hyperthermic-
level perfusion values. Additionally, heating with radiative
and capacitive systems was simulated and compared for
small (i.e. slender) fatless, small (i.e. fat layer typically <2 cm)
and large (i.e. overweight/obese, fat layer typically >3 cm)
patients with cervix, prostate, bladder or rectum tumours.
The quality of the simulated target heating was quantified in
terms of tumour temperatures that could be realised without
overheating normal tissue.
Methods
Simulations were performed using our in-house developed
hyperthermia treatment planning software, Plan2Heat, which
uses voxel-based finite difference calculations [31].
Validations of the software for applications similar to the
work described in this paper have been reported earlier
[31,32]. The resolution applied for all simulations was
2.5 2.5 2.5mm3. The definitions of the radiative heating
system, electrodes and water boluses were generated using
the Generic Object Format [33].
Radiative and capacitive heating systems
The AMC-4 phased array system was modelled to represent
radiative heating devices [22]. This system consists of four
rectangular waveguides operating at 70MHz. Phases and
amplitudes of the individual antennas can be adapted to
focus heating to the target region. Water bolus cooling with
circulating deionised water at 12 C was simulated to avoid
overheating of the skin, similar to clinical practice [34]. A typ-
ical (minimum) bolus thickness of 5 cm was assumed.
For capacitive heating systems, different sizes of electrodes
are available, varying between 4 and 30 cm in diameter
[17,35–39]. When two different sizes of electrodes are applied,
the heating is focussed towards the smaller electrode. The
modelled electrode combinations had diameters of 25 and
25 cm, 20 and 25 cm or 15 and 25 cm, respectively, and an
operating frequency of 13.56MHz was assumed. For the elec-
trode bolus filling circulating saline (0.4% NaCl [17,32]) or dis-
tilled water were modelled. Some clinics combine saline
boluses with an overlay bolus for more aggressive cooling
[14,40,41]. Different clinically used bolus temperatures for cap-
acitive heating were modelled: a saline electrode bolus at
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10 C or 0 C, a distilled water electrode bolus at 10 C or 0 C
and a saline electrode bolus combined with an overlay bolus
at 0 C [17,40]. The simulated salinity for the combination with
an overlay bolus was based on the study of Kato [16]. A typical
thickness of the electrode bolus and overlay bolus of 1.5 cm
and 2.5 cm was assumed, respectively [30]. A schematic rendi-
tion of the heating systems is shown in Figure 1.
Phantom simulations
Phantom simulations were performed for four different per-
fused models to analyse the basic heating properties of
radiative and capacitive hyperthermia systems (see Figure 1):
 Small homogeneous phantom: a fatless cylindrical muscle-
equivalent phantom with dimensions 30 20 50 cm3.
 Large homogeneous phantom: a fatless cylindrical muscle-
equivalent phantom with dimensions 45 30 50 cm3.
 Small inhomogeneous phantom: a cylindrical fat-muscle
phantom with dimensions 30 20 50 cm3. The thickness
of the fat layer is 1 cm.
 Large inhomogeneous phantom: a cylindrical fat-muscle
phantom with dimensions 45 30 50 cm3. The thickness
of the fat layer is 2 cm.
For all phantoms, a central and eccentric spherical target
volume with a diameter of 5 cm was modelled. The eccentric
location was shifted 4.5 cm towards the top compared with
the central target, which is representative for the typical
eccentric location of bladder and rectum tumours. This allows
to compare the basic heating characteristics for small and
large anatomies and highlights differences in heating princi-
ples when tissue heterogeneities are present.
For capacitive heating, the two electrodes were modelled
positioned at the top and bottom as well as at the sides of
the phantoms, to determine differences in heating effective-
ness. To minimise excessive heating of normal tissue the
strategy of switching the electrode positions from topþ
bottom to leftþ right was also investigated. The best pos-
sible heating that could theoretically be achieved with this
switching was simulated by assuming a continuous short
duty cycle (e.g. 30 s). Thermal simulations for this situation
therefore assumed the power distribution to be the average
of the power distribution generated by electrodes at the
topþbottom and leftþ right, combined with continuous
bolus cooling at all four sides of the phantom.
Another commonly used strategy to reduce superficial
hot spots during capacitive heating is precooling before the
start of the treatment. The effect of 15min precooling
with saline water boluses at 10 C on hot spot occurrence
and target heating was evaluated for the small inhomogen-
eous phantom.
Patient simulations
Patient simulations were performed for the most common
pelvic tumour locations for which locoregional hyperthermia
is applied: cervix, prostate, bladder and rectum. Small (i.e.
slender) fatless, small and large (i.e. overweight/obese)
patient models were derived from standard clinical CT data
sets, scanned in the past 2 years. Scans should have been
Figure 1. Schematic representation of the capacitive and radiative heating systems and the phantoms used in the simulations. The AMC-4 system consists of four
rectangular waveguides, which were positioned around the phantom. Capacitive electrodes were positioned at the top and bottom of the phantom, at the sides, or
alternatingly at the top and bottom and at the sides.
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made in supine position and should be free of severe arte-
facts. For each tumour site, the patient with the thinnest fat
layer and a patient with a large fat layer (>3 cm) were
selected. Figure 2 shows transversal slices of the selected CT
scans at the centre of the tumour. Fat layers were measured
in anterior posterior direction in the slices at the centre of
the tumour. For the small patients, the maximum fat layers
were as follows: cervix 1.1–2.2 cm, prostate 2.4–4.1 cm, blad-
der 0.9–1.4 cm, rectum 1.4–1.5 cm, and for the large patients
maximum fat layers were as follows: cervix 3.3–4.6 cm,
prostate 3.4–5.4 cm, bladder 3.3–4.2 cm, rectum 2.4–5.5 cm
(Figure 2). The bladder cancer patients had a full bladder,
since these were treated with hyperthermia and intravesical
mitomycin C. Tissue segmentation was performed using
Hounsfield unit thresholds [42], distinguishing muscle, fat,
bone and air. The small fatless patient model was created
from the small patient model by replacing all fat tissue with
muscle tissue. Contrast regions and other small artefacts, if
present, were corrected manually. The tumour/target volume
was delineated manually by a physician. Then the anatomy
was combined with the model of the AMC-4 system or the
capacitive electrodes and boluses.
SAR calculations
For radiative heating, the electromagnetic field was calcu-
lated by solving Maxwell’s equations using the finite differ-
ence time domain (FDTD) method [43]. A perfectly matched
layer boundary condition was applied [44]. From the electric
field vector (~E), the power density (PD) or specific absorption
rate (SAR) can be calculated using
PD ¼ r
2
k~E k2 ¼ q  SAR (1)
with r (S m1) the electrical conductivity and q (kgm3) the
tissue density.
Because of the low frequency applied for capacitive heat-
ing, power distributions were calculated by solving the
quasi-static formulation of Maxwell’s equations. Kroeze et al.
demonstrated that this is a valid approach for treatment
planning for capacitive hyperthermia [32]. The electric field
vector can be written as ~E ¼ rV . This quasi-static formula-
tion yields an elliptic partial differential equation to be
solved for the potential V [45]. The electrode plates at the
top and bottom were kept at a constant potential of 1 V
and 1 V, respectively. The boundaries of the simulation
domain were fixed at zero potential. The dielectric proper-
ties used for the simulations were taken from the literature
[46,47] (Table 1) and were considered constant, since the
variation of dielectric properties with temperature in the
range between 37 C and 44 C is small [48]. Some literature
suggests that the electrical conductivity of human tumours
could be about 10% higher than the conductivity of normal
tissue [49,50]. To evaluate the possible effect of such a con-
trast in tissue properties on the heating effectiveness,
patient simulations as described above were compared with
simulations with a 10% increase in electrical conductivity for
the target region compared with the values listed in
Table 1.
Figure 2. Transversal cross-sections of the CT scans for small (i.e. slender) and large (i.e. overweight/obese) cervix, prostate, bladder and rectum cancer patients.
The scans of the cervix and bladder cancer patients were standard hyperthermia treatment planning scans for heating with the AMC-4 system, scanned in treatment
position, i.e. on a water bolus and mattressess. The prostate and rectum cancer patients were not treated with the AMC-4 system and standard radiotherapy
scans were used, recorded on the table of the linear accelerator. Measured fat layer thicknesess are indicated and the red contour represents the target region.
Cross-sections are at the centre of the target region in axial direction.
Table 1. Values of the dielectric properties at 13.56MHz and 70MHz used in
the simulations [46]; conductivity (r [S m1] and relative permittivity (er []).
13.56MHz 70MHz
r (S m1) er () r (S m1) er ()
Air 0 1 0 1
Bone 0.05 30.6 0.06 16.4
Fat 0.03 11.8 0.04 6.4
Fat (target) 0.03 11.8 0.04 6.4
Muscle 0.63 138.4 0.69 70.8
Muscle (target) 0.63 138.4 0.69 70.8
Water (distilled, 0 C) 9.4e-5 87.7 – –
Water (distilled, 10 C) 6.4e-5 83.8 – –
Water (distilled, 12 C) – – 1.6e-3 83.0
Water (saline, 0.4% NaCl, 0 C) 0.39 86.2 – –
Water (saline, 0.4% NaCl, 10 C) 0.51 82.4 – –
Water (saline, comb. overlay, 0 C) 3.0 73.5 – –
Water (overlay bolus, 0 C) 0.45 78.6 – –
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Temperature calculations
Thermal simulations were performed by solving Pennes’ bio
heat equation [51]:
cq
@T
@t
¼ r  ðktisrTÞ  cbWbðT  TartÞþPD (2)
with c the specific heat capacity (J kg1 C1). The first term
on the right hand side represents the heat conduction in tis-
sue, with ktis (Wm
1 C1) the thermal conductivity. The
second term models the perfusion, with cb the specific heat
capacity of blood, Wb (kgm
3 s1) the volumetric perfusion
rate and Tart the local arterial or body core temperature.
Density and thermal properties were taken from the litera-
ture and are listed in Table 2 [46,47]. The initial temperature
for all phantom and patient simulations was 37 C. Constant
hyperthermic-level perfusion values were assumed and con-
stant temperature boundary conditions were applied outside
the phantom or patient. An effective conductivity for the
water boluses was modelled to account for the fluid dynam-
ics [52].
For capacitive heating, steady state temperatures were cal-
culated with the total absorbed power for each individual
situation scaled such that the maximum temperature was
44 C. For radiative heating with the AMC-4 system, steady
state temperature-based phase amplitude optimisation was
performed, in which the temperature at least achieved in
90% of the target (i.e. T90) was maximised with constraints of
44 C to normal tissue.
Analysis
For the phantom models, simulated temperature distributions
were compared for radiative and capacitive heating.
Differences in heating effectiveness for homogeneous and
inhomogeneous situations were analysed as well as the
impact of bolus filling, bolus temperature, precooling and
switching electrode positions in the case of capacitive heat-
ing. The simulated temperature distributions were compared
quantitatively by means of the indexed temperature T90,
which is correlated to clinical outcome [5,53]. The indexed
temperature T90 is defined as the temperature at least
achieved in 90% of the target volume. Additionally, the
simulated total absorbed power in the phantom and the tar-
get were compared.
For the patient models, the simulated temperature distri-
butions were compared for both heating techniques.
Differences in simulated heating effectiveness for small and
large patients were analysed for each tumour site and quan-
tified by the simulated target T10, T50 and T90 and the total
power absorbed in the patient and the target region.
Definitions of T10 and T50 are analogous to the definition
of T90.
Results
Phantom simulations
Homogeneous phantoms
Figure 3 compares heating of a small and large homoge-
neous muscle-equivalent phantom with the AMC-4 system
and with capacitive electrodes positioned at the top and bot-
tom of the phantom, at the sides, or alternatingly at the top
and bottom and at the sides. For a fair comparison between
electrodes positioned at the top and bottom, at the sides or
alternatingly, both electrodes had a diameter of 25 cm. The
simulated T90 for a central or eccentric target location is
shown. The maximum temperature in the phantom is 44 C
for all cases. Optimized antenna settings for the AMC-4 sys-
tem are listed in Table 3. Simulated target temperatures
decrease with increasing dimensions of the phantom for
both heating techniques, because of the increasing distance
of the antennas/electrodes to the target. For capacitive heat-
ing, a saline electrode bolus yields a better performance than
a bolus with distilled water, with differences up to 0.6 C for
standard heating using top and bottom electrodes. More
aggressive cooling at 0 C instead of 10 C slightly improves
target heating up to 0.2 C. The use of a saline electrode
bolus in combination with an overlay bolus is optimal for
capacitive heating and can increase target temperatures with
1.5 C compared with a saline electrode bolus alone. For
the small phantom, the predicted temperatures for radiative
and capacitive heating were comparable (42 C) and the
maximum temperature of 44 C is in the target, so heating is
not limited by hot spots. For the large homogeneous phan-
tom, capacitive heating shows up to 2 C higher predicted
target temperatures than the radiative AMC-4 system.
Table 2. Values of the density and thermal properties used in the simulations [47]; density (q [kg m3]), specific heat cap-
acity (c [J kg1 C1]), thermal conductivity (k [W m1 C1]) and perfusion (Wb [kg m
3 s1]).
q (kg m3) c (J kg1 C1) k (W m1C1) Wb (kg m
3 s1)
Air 1.29 1000 0.024 0
Bone 1908 1313 0.32 0.12
Fat 911 2348 0.21 1.1
Fat (target) 911 2348 0.21 1.1
Muscle 1090 3421 0.49 3.6
Muscle (target) 1090 3421 0.49 1.8
Water (distilled, 0 C) 1000 4180 6.0 –
Water (distilled, 10 C) 1000 4180 6.0 –
Water (distilled, 12 C) 1000 4180 0.6 –
Water (saline, 0.4% NaCl, 0 C) 1000 4180 6.0 –
Water (saline, 0.4% NaCl, 10 C) 1000 4180 6.0 –
Water (saline, comb. overlay, 0 C) 1000 4180 6.0 –
Water (overlay bolus, 0 C) 1000 4180 6.0 –
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This can be explained by the higher frequency used in
the radiative system, leading to a higher absorption of
the electromagnetic field in the superficial layers of the
homogeneous phantom, and consequently to a lower
penetration depth into the phantom. Both the central and
the eccentric target region are heated effectively, though
the predicted temperature in the eccentric target is
slightly higher.
Figure 3. Simulated T90 target temperatures for small (Aþ B) and large (CþD) homogeneous phantoms, with a central or eccentric target volume, heated by two
25 cm diameter capacitive electrodes with different boluses (saline, distilled water, salineþ overlay bolus) or the radiative AMC-4 system. Capacitive electrodes were
positioned at the top and bottom of the phantom, at the sides or alternatingly.
Table 3. Power contribution and phase settings for the antennas of the AMC-4 system, as numerically optimised to simulate target heating with the highest
T90, with constraints of 44 C to all tissues.
Power contribution (%) Phase ()
Top Bottom Left Right Top Bottom Left Right
Phantomsa
Small homogeneous, central 37.9 37.9 12.1 12.1 0 0 102 102
Small homogeneous, eccentric 49.2 29.9 8.1 12.7 0 35 27 9
Small inhomogeneous, central 28.0 28.0 22.0 22.0 0 0 112 112
Small inhomogeneous, eccentric 49.8 17.8 17.7 14.7 0 44 21 31
Large homogeneous, central 28.2 28.3 21.8 21.7 0 0 56 54
Large homogeneous, eccentric 28.6 28.6 21.4 21.4 0 47 73 74
Large inhomogeneous, central 36.7 36.7 13.3 13.3 0 0 57 57
Large inhomogeneous, eccentric 40.7 29.2 15.1 15.1 0 61 78 78
Patients
Cervix, small fatless 18.0 4.6 42.8 34.7 0 67 61 48
Prostate, small fatless 26.8 23.4 27.1 22.7 0 53 35 1
Bladder, small fatless 17.9 6.1 30.0 45.9 0 79 26 42
Rectum, small fatless 9.6 12.8 20.0 57.7 0 14 28 71
Cervix, small 14.5 11.9 36.7 36.8 0 34 109 102
Prostate, small 11.8 33.6 21.1 33.5 0 18 107 109
Bladder, small 22.8 19.0 12.2 46.0 0 20 41 47
Rectum, small 3.0 21.5 47.2 28.2 0 119 162 147
Cervix, large 29.2 22.0 24.6 24.2 0 33 106 101
Prostate, large 19.6 28.2 24.1 28.2 0 49 59 53
Bladder, large 23.6 30.0 18.9 27.5 0 20 78 89
Rectum, large 18.2 32.4 22.1 27.4 0 22 73 94
aSlight asymmetries in antenna settings could occur for symmetric situations as a result of the Yee-cell used in FDTD calculations [83]. Moreover, optimal settings
found are not necessarily unique and other settings might yield similar effective target heating with a different pattern of normal tissue heating.
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Positioning the electrodes at the top and bottom of the
phantom is clearly more effective than heating with electro-
des positioned at the sides, which can be explained by the
smaller distance to the target, similar to heating a smaller
phantom. However, heating by electrodes at the sides can be
used in combination with heating by electrodes at the top
and bottom to lower the average amount of power absorbed
in superficial layers of normal tissue. Heating alternatingly
with a short duty cycle through electrodes at the top and
bottom or at the sides can improve target heating, especially
for the large phantom. Nevertheless, in general the predicted
differences with heating using top and bottom electrodes
combined with overlay boluses are small.
Figure 4 compares the target T90 predicted for different
top and bottom electrode combinations, i.e. 25þ 25 cm,
20þ 25 cm and 15þ 25 cm. The combination with two
equally sized electrodes yields the highest T90 both for the
central and eccentric target region. When different sizes of
electrodes are combined, the focus of the power absorption
is directed towards the smallest electrode. When using differ-
ent sizes of electrodes for the small phantom with eccentric
target, the maximum temperature of 44 C is still predicted
in the target, but the deepest part of the target is less effect-
ively heated compared with equally sized electrodes, which
explains the lower T90. For the large phantom, the direction
of the power towards the smallest electrode gives rise to hot
spots between the bolus of the smallest electrode and the
target region and limits effective target heating.
Figure 5 shows the simulated temperature distributions in
the central transversal slice for the small and large homoge-
neous phantoms heated with the AMC-4 system or capacitive
electrodes with a saline electrode bolus and overlay bolus.
These pictures show that radiative and capacitive heating are
equally effective in target heating for the small phantom.
However, for the eccentric target location capacitive heating
is more target-selective since the maximum normal tissue
temperature is 2 C lower compared with the maximum tar-
get temperature of 44 C, while for radiative heating the
maximum normal tissue temperature is also 44 C. For the
large phantom, capacitive heating is more effective and
superficial hot spots can be observed with both techniques.
The power absorbed in the target region is typically smaller
for the large phantom compared to the small one. The same
holds for the central target compared to the eccentric target.
Inhomogeneous phantoms
Figure 6 shows the simulated T90 for the small and large
inhomogeneous fat-muscle phantom, with a central or eccen-
tric target location, heated with the AMC-4 system or capaci-
tive electrodes with a diameter of 25 cm. Figure 7 compares
different top and bottom electrode combinations, i.e.
25þ 25 cm, 20þ 25 cm and 15þ 25 cm, and Figure 8 shows
the temperature distributions for the inhomogeneous phan-
toms. Again, outside the target region the maximum tem-
perature is 44 C for all cases. General aspects about
Figure 4. Simulated T90 target temperatures for small (Aþ B) and large (CþD) homogeneous phantoms, with a central or eccentric target volume, heated by dif-
ferent combinations of capacitive electrodes (diameters 25þ 25 cm, 20þ 25 cm or 15þ 25 cm) with different boluses (saline, distilled water, salineþ overlay bolus)
or the radiative AMC-4 system. Capacitive electrodes were positioned at the top and bottom of the phantom.
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phantom sizes, bolus filling, water bolus temperature, dis-
tance from the antennas or electrodes to the target etc., as
mentioned above for the homogeneous phantoms are also
valid for the inhomogeneous phantoms. The use of an
overlay bolus still shows the best performance for capacitive
heating, but the differences compared with a saline electrode
bolus only is now reduced to 0.1–0.2 C. Target heating for
inhomogeneous phantoms is limited by hot spots in normal
Figure 6. Simulated T90 target temperatures for small (Aþ B) and large (CþD) inhomogeneous phantoms, with a central or eccentric target volume, heated by
two 25 cm diameter capacitive electrodes with different boluses (saline, distilled water, salineþ overlay bolus) or the radiative AMC-4 system. Capacitive electrodes
were positioned at the top and bottom of the phantom, at the sides, or alternatingly.
Figure 5. Simulated temperature distributions for heating of the homogeneous phantoms with capacitive electrodes (25þ 25 cm) using overlay boluses and the
radiative AMC-4 system. The maximum temperature in all distributions is 44 C. The total power absorbed in the phantom (Ptot) and in the target region (Ptarget) is
indicated for each distribution.
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tissue for all cases, both for capacitive and radiative heating.
Simulated target temperatures are substantially lower using
capacitive electrodes compared with the radiative AMC-4 sys-
tem, which implies that the hot spots at the fat-muscle
interface are more treatment limiting with capacitive heating
compared with radiative heating. Differences in predicted tar-
get T90 are 2–4 C. The T90 predicted with capacitive heat-
ing is very low for both the small and the large
Figure 7. Simulated T90 target temperatures for small (Aþ B) and large (CþD) inhomogeneous phantoms, with a central or eccentric target volume, heated by dif-
ferent combinations of capacitive electrodes (diameters 25þ 25 cm, 20þ 25 cm or 15þ 25 cm) with different boluses (saline, distilled water, salineþ overlay bolus)
or the radiative AMC-4 system. Capacitive electrodes were positioned at the top and bottom of the phantom.
Figure 8. Simulated temperature distributions for heating of the inhomogeneous phantoms with capacitive electrodes (25þ 25 cm) using overlay boluses or the
radiative AMC-4 system. The maximum temperature in all distributions is 44 C. The total power absorbed in the phantom (Ptot) and in the target region (Ptarget) is
indicated for each distribution.
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inhomogeneous phantom. A target T90< 37.5 C is observed
for the large phantom.
Effect of precooling
Precooling is often applied in the clinic to reduce the inci-
dence of treatment limiting hot spots with capacitive heat-
ing. The effect of 15min precooling with saline water boluses
at 10 C was evaluated for the small inhomogeneous phan-
tom with a central target. Figure 9 shows the simulated
transient temperature development with and without pre-
cooling for a superficial hot spot location at the fat–muscle
interface (i.e. at 1 cm depth) and the centre of the target
region. The temperature development was evaluated at the
voxel of the hot spot and at the central voxel of the target
region. Precooling affects neither the central target tempera-
ture nor the steady-state hot spot temperature. However,
when precooling is applied the critical temperature of 44 C
at the hot spot location is reached with a delay of a
few minutes.
Patient simulations
Figure 10 shows the indexed target temperatures T10, T50
and T90 for the small fatless, small and large patients with
cervix, prostate, bladder and rectum cancer, heated with cap-
acitive electrodes or the radiative AMC-4 system. For capaci-
tive heating, standard topþbottom electrodes were used
with saline electrode boluses in combination with overlay
boluses, as this showed optimal performance in the phantom
simulations. The maximum tissue temperature was 44 C for
all cases. Optimized antenna settings for the AMC-4 system
are listed in Table 3.
For the small fatless patients, capacitive heating predicts
adequate target temperatures for all cases, with simulated
T90 values above 39.5 C. Heating with the radiative AMC-4
system is predicted to be even more effective, with T90
Figure 9. Transient temperature development in the central target region and
at a superficial hot spot location at the fat-muscle interface (i.e. at 1 cm
depth) for capacitive heating of the small inhomogeneous phantom with and
without 15min precooling using a saline bolus at 10 C.
Figure 10. Simulated indexed target temperatures T10, T50 and T90, for small fatless, small and large cervix, prostate, bladder and rectum cancer patients heated
with capacitive electrodes using overlay boluses with different combinations of capacitive electrodes (diameters 25þ 25 cm for cervix and prostate and diameters
25þ 25 cm, 20þ 25 cm or 15þ 25 cm for bladder and rectum) or the radiative AMC-4 system.
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values above 41.5 C. However, for the small patients with
realistic fat layers the predicted differences in performance
are more pronounced. For the centrally located cervix and
prostate tumours predicted target temperatures remained
between 37 and 38 C for capacitive heating, while with
radiative heating a T90 of 40.2 C and 38.7 C were simulated
for the small patient, respectively. Although mild tempera-
tures of about 39 C are considered sub-optimal, still some
relevant positive biological effects on enhancement of radio-
therapy (e.g. re-oxygenation by increased blood flow) are
expected [54]. However, in view of the clinically established
thermal dose-effect relationship treatment outcome is likely
to improve with increasing target temperatures [3,5,9].
For the more eccentrically located bladder and rectum
tumours, capacitive heating was predicted to perform better
than for the centrally located tumours. Different sizes of elec-
trodes are clinically used to focus heating towards eccentric
locations. However, the anatomy and the exact location of
the target determine whether different sizes of electrodes
improve target heating compared with equally sized electro-
des. Figure 10(C) shows that for the small fatless bladder
cancer patient results are in correspondence with the
phantom simulations and equally sized electrodes yield the
best predicted temperatures, while for the small bladder
patient a smaller top electrode indeed improves target
coverage. For the small patient, the simulated T90
increased from 37.9 C to 38.2 C when a top electrode
with a diameter of 15 cm instead of 25 cm was used. For the
rectum tumour (Figure 10(D)), which is more deep-seated
than the bladder tumour, this had no effect and the T90 for
the small rectum cancer patient was 37.7 C. Since the simu-
lated T50 and T10 were also below 39 C, such a treatment
would not be expected to be very effective [54]. For these
eccentric tumours, radiative heating was again much more
effective: the T90 simulated with the AMC-4 system was
41.7 C and 40.1 C for the small bladder and rectum cancer
patients, respectively. These simulated temperatures are in
the therapeutic range and thus can be expected to yield an
effective treatment [54]. Figure 11 shows that a 10% increase
in conductivity of the tumour target region, an increase
sometimes found in the literature [49,50], has a negligible
effect on simulated tumour temperature levels.
In general, large patients are more difficult to heat and as
for the phantom simulations, again a better target heating
was simulated for the smaller patients, both with capacitive
and radiative heating. However, in large patients almost no
target heating was predicted with capacitive heating without
overheating normal tissue, while for radiative heating still T90
temperatures above 38 C were predicted and T50 was above
39 C in most cases.
Figures 12 and 13 show transversal and sagittal slices of
the simulated temperature distributions for the small fatless
cervix, prostate, bladder and rectum patients. These distribu-
tions demonstrate that capacitive heating could realise thera-
peutic heating when (superficial) fat layers are absent.
Nevertheless, even in those cases a more pronounced
Figure 11. Simulated indexed target temperatures T10, T50 and T90, for small cervix, prostate, bladder and rectum cancer patients with normal electrical conductivity
of the target region, or 10% enlarged values of the electrical conductivity. Heating was simulated with capacitive electrodes using overlay boluses with different
combinations of capacitive electrodes (diameters 25þ 25 cm for cervix and prostate and diameters 25þ 25 cm, 20þ 25 cm or 15þ 25 cm for bladder and rectum)
or the radiative AMC-4 system.
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heating focus is predicted for heating with the radiative
AMC-4 system. Figures 14 and 15 show the simulated distri-
butions for the small patients. These figures demonstrate the
limited deep-seated heating using capacitive electrodes due
to the incidence of superficial hot spots, despite the aggres-
sive skin cooling. With radiative heating, hot spots are less
treatment limiting and higher temperatures are predicted at
deep-seated locations, although a pronounced heating focus
in the target region is not observed due to treatment limit-
ing hot spots (with exception of the bladder). This is also
reflected in the total power absorbed in the patient and in
the target region, which is substantially larger for radia-
tive heating.
Discussion
In this study, a comparison of temperature distributions in
perfused small and large muscle tissue and fat–muscle phan-
toms as well as small and large cervix, prostate, bladder and
rectum cancer patients showed that radiative hyperthermia is
generally more effective in heating deep-seated pelvic
tumour locations than capacitive hyperthermia. Substantially
higher target temperatures (1–3 C higher T90) were pre-
dicted with radiative heating before treatment limiting hot
spots in normal tissues occurred. These results confirm and
extend observations of Kroeze et al., who demonstrated for a
single prostate cancer patient that adequate tumour
Figure 12. Transversal slices of the simulated temperature distribution for small fatless cervix, prostate, bladder and rectum cancer patients heated with capacitive
electrodes (25þ 25 cm) using overlay boluses or the radiative AMC-4 system. The maximum temperature in all distributions is 44 C. The total power absorbed
in the patient (Ptot) and in the target region (Ptarget) is indicated for each distribution. Cross-sections are at the centre of the target region in axial direction. The
contour in the temperature distributions indicates the target region.
Figure 13. Sagittal slices of the simulated temperature distribution for small fatless cervix, prostate, bladder and rectum cancer patients heated with capacitive
electrodes (25þ 25 cm) using overlay boluses or the radiative AMC-4 system. The maximum temperature in all distributions is 44 C. The total power absorbed in
the patient (Ptot) and in the target region (Ptarget) is indicated for each distribution. Slices were taken approximately through the centre of the patient. The contour
in the temperature distributions indicates the target region.
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temperatures can only be obtained with capacitive heating
when accepting very high temperatures in the superficial fat
and muscle layers [30,32].
Results of the present study showed that large patients
with deep-seated tumours are more difficult to heat than
small patients, both for capacitive and radiative heating. This
can be explained by the larger distance of the electrode/
antenna to the target location. This phenomenon is also
observed in the clinic, as described by Van Haaren et al., who
demonstrated that intra-oesophageal temperatures during
locoregional hyperthermia are inversely related to patients’
body size parameters, of which fat percentage is the most
significant prognostic factor [55]. Hiraoka et al. also observed
that the heating efficacy decreased with increasing fat thick-
ness in a study with a diverse patient population consisting
of deep-seated malignancies in the upper abdomen, lower
abdomen, pelvis, thorax, the head and neck and lower
extremities [12].
We simulated a number of strategies to improve the
effectiveness of capacitive heating. The water bolus filling
has some influence on the predicted temperature distribution
with capacitive heating and the use of a saline electrode
bolus combined with an overlay bolus as proposed by Kato
[16], provides very aggressive cooling of the skin such that
higher tumour temperatures could be achieved compared
with saline or distilled water filled electrode boluses only.
Figure 14. Transversal slices of the simulated temperature distribution for small cervix, prostate, bladder and rectum cancer patients heated with capacitive electro-
des using overlay boluses or the radiative AMC-4 system. Electrode sizes topþ bottom were 25þ 25 cm (cervix, prostate, rectum) and 15þ 25 cm (bladder). The
maximum temperature in all distributions is 44 C. The total power absorbed in the patient (Ptot) and in the target region (Ptarget) is indicated for each distribution.
Cross-sections are at the centre of the target region in axial direction. The contour in the temperature distributions indicates the target region.
Figure 15. Sagittal slices of the simulated temperature distribution for small cervix, prostate, bladder and rectum cancer patients heated with capacitive electrodes
using overlay boluses or the radiative AMC-4 system. Electrode sizes topþ bottom were 25þ 25 cm (cervix, prostate, rectum) and 15þ 25 cm (bladder). The max-
imum temperature in all distributions is 44 C. The total power absorbed in the patient (Ptot) and in the target region (Ptarget) is indicated for each distribution.
Slices were taken approximately through the centre of the patient. The contour in the temperature distributions indicates the target region.
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Precooling is often applied clinically in order to reduce
the incidence of treatment limiting hot spots with capacitive
heating [56], even though clinical experience shows that this
is not always effective in avoiding preferential heating at
fat–muscle interfaces [57]. Simulations showed that despite
the precooling the same steady state temperature is pre-
dicted, both at the superficial hot spot and at the target
location. Precooling in combination with switching the active
electrodes from top and bottom to the sides can improve
patient comfort since hot spot complaints are resolved tem-
porarily. However, the target temperature is not expected to
improve sufficiently to realise a substantial improvement in
treatment outcome. The simulations performed in this study
for alternatingly heating with electrodes at the top and bot-
tom and at the sides assumed a continuous switching with a
very short duty cycle (e.g. 30 s) and continuous overall skin
cooling to model the optimal result that can theoretically be
achieved with this switching technique. However, steady
state temperatures were very similar to those predicted with
electrodes at the top and bottom using saline electrode
boluses in combination with overlay boluses. The fundamen-
tal problem that causes the treatment limiting hot spots is
the E-field direction that is perpendicular to the fat–muscle
interface in combination with the lack of steering possibil-
ities. Switching electrode positions does not overcome these
fundamental problems, but continuously changes the loca-
tion of the treatment limiting hot spot which does improve
the target temperature, but again not sufficiently to meet
the clinical requirements. Moreover, switching active elec-
trode positions makes the treatment more complicated and
it is only feasible with more flexible capacitive heat-
ing systems.
The differences in behaviour between capacitive and
radiative heating can be explained by evaluating the electro-
magnetic field emitted by the two systems. The capacitive
electrodes produce an electric field (E-field) that is oriented
mainly perpendicular to the superficial fat–muscle interfaces,
while for the radiative antennas the main E-field direction is
parallel to the superficial fat–muscle interfaces. The interface
conditions derived from Maxwell’s equations prescribe that
the tangential E-field is continuous, while the normal E-field
component undergoes a discontinuity proportional to the
dielectric properties of the two different tissues. This yields a
much higher value of the electric field in the fat tissue for
the capacitive systems, which explains the treatment limiting
hot spots. Moreover, the possibility to focus the electromag-
netic field is very minimal with capacitive heating, since only
different electrode sizes can be chosen. Radiative heating is
typically performed with phased-array systems providing
phase-amplitude steering to focus heating to the target and
minimise hot spots. This explains that treatment limiting hot
spots at fat-muscle tissue interfaces are more dominant for
capacitive heating than for radiative heating and that adapta-
tions in bolus cooling etc. to improve capacitive heating only
have a limited effect.
Capacitive and radiative heating were compared using
treatment planning to demonstrate qualitative differences
between heating effectiveness. Treatment planning has been
successfully applied for similar applications comparing
different heating techniques, frequencies and antenna
designs [18,20,26,58–60]. Planning is very reliable for applica-
tion in phantoms with known material properties. However,
quantitative results are less reliable in clinical application due
to the uncertainties in exact tissue properties and perfusion,
so the results can only be translated qualitatively to clinical
settings, both for capacitive and radiative heating. For some
cases hardly any temperature rise was predicted in the target
region for capacitive heating, and in reality for these cases
the target temperature might be increased for example with
1–2 C, since a clinical study by Ohguri et al. reports a
median T90 between 38 C and 39 C for cervical cancer
patients [3]. A temperature-dependent perfusion model could
improve the reliability of the thermal simulations [61–63], but
requires very long computation times and uncertainties in
the exact perfusion values will still remain. We chose to use
perfusion values which are representative when tissues are
subjected to hyperthermic temperature levels, but higher
than the perfusion values expected at temperatures <38 C.
This will lead to a slight underestimation of the lowest pre-
dicted temperature increase. All normal tissue constraints
were set to 44 C, while some studies report that patients
can tolerate fat temperatures of 45 C before complaining
[57], which would imply that all target temperatures could
increase with roughly 15%, both for radiative and capacitive
heating. However, since important model parameters in this
study, such as tissue properties, perfusion values and tem-
perature constraints, were the same for both capacitive and
radiative heating, the qualitative differences in predicted
temperatures between capacitive and radiative heating will
remain valid, despite the uncertainties in (thermal) modelling.
Clinical treatment planning has proven to be effective in pre-
dicting qualitative differences in heating quality. For example,
Sreenivasa et al. reported that treatment planning can pre-
dict whether patients are easy-to-heat or difficult-to-heat
[64], and Kok et al. demonstrated that treatment planning is
effective to predict relative differences in heating pat-
terns [65–67].
For radiative heating, the 2D 70MHz AMC-4 phased array
system was modelled in this study. Other radiative locore-
gional heating systems are commercially available, such as
the 75–120MHz BSD-2000 Sigma-60 system [21], the
100MHz BSD-2000 Sigma-Eye system [19] and the 70MHz
ALBA 4D system [68]. Such phased array systems all provide
phase-amplitude steering to focus the electromagnetic
energy and avoid hot spots [69]. Some of these systems pro-
vide 3D steering to realise a more favourable power and
temperature distribution compared with 2D steering.
Therefore, the qualitative differences in heating quality in
favour of radiative heating as demonstrated in this paper will
be generally valid for 2D radiative heating systems and can
be even slightly larger for 3D systems.
Although this study showed that capacitive heating is in
general much less effective compared with radiative heating
for deep-seated pelvic tumours, capacitive heating can be of
clinical value for some specific patient categories. The phan-
tom and patient simulations in this paper showed very
effective target heating when no fat layer is present. This
was also demonstrated in a recent phantom study by
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Sahinbas et al. [70], who performed measurements in an agar
phantom as well as in the Alderson radiotherapy phantom,
which represents soft tissue, lung tissue and bone. These
results show that for very slender patients with almost no
fat, capacitive heating can be effective for deep-seated
tumours. This is confirmed by several positive clinical studies
using capacitive heating. For example, Hiraoka et al. reported
temperatures >41 C in clinical applications [11], and Harima
et al. reported an increase in 3-year overall survival for stage
IIIB cervical carcinoma from 48.1% with radiation alone to
58.2% with radiation plus capacitive heating [71]. Clinical
results of Ohguri et al. for Japanese cervical cancer patients,
showed that the 26 out of 47 patients with a CEM43T90> 1
showed a significantly better clinical outcome than the
remaining 21 patients who proved impossible to heat with a
CEM43T90< 1 [3]. Pancreatic cancer patients tend to be
more slender than other categories, so fat may be nearly
absent in pancreatic cancer patients and clinical temperature
data reported from small patients series indicate that thera-
peutic temperatures exceeding 42 C are achievable for this
patient category using capacitive devices [72–74].
Our predictions suggest that eccentrically located tumours
(i.e. rectum and bladder) do relatively better for capacitive
heating compared with centrally located tumours (i.e. cervix
and prostate). Accordingly, another patient category for
which capacitive heating might be considered is large eccen-
trically located bulky tumours, such as breast tumours or
head and neck tumours. Clinical studies report feasibility of
heating bulky tumours with capacitive systems with tumour
temperatures in the therapeutic range (40–44 C) [17,75–77].
Some caution is required though, since clinically measured
temperatures using a limited number of thermometry probes
do not provide full information about the 3D temperature
distribution and extensive thermometry would be necessary
to avoid missing hot spots that could lead to subcutaneous
burns [57]. Van Wieringen et al. described clinical application
of capacitive heating with a 70MHz CFMA for 6 patients with
bulky breast tumours and concluded that the penetration
depth is adequate and acceptable temperatures were real-
ised, but temperature distributions were very heterogeneous
and hot spots were often treatment limiting [78]. A study by
Kok et al. compared radiative and capacitive heating with a
70MHz CFMA for a bulky tumour on the leg, and retrospect-
ive treatment planning results corresponded qualitatively to
temperatures measured during clinical treatments [28,29].
This study showed that with radiative heating a better
tumour coverage was achieved. Again, with capacitive heat-
ing treatment limiting hot spots were more dominant.
Although the dominant E-field component is not perpendicu-
lar but parallel to the fat-muscle interface for the capacitive
70MHz CFMA, the perpendicular E-field component is still
relatively high, which explains the treatment limiting hot
spots [78]. Thus, in general a better tumour coverage is
expected when using radiative heating, also for
bulky tumours.
For superficial tumours infiltrating up to 4 cm into tissue,
such as chest wall recurrences, capacitive heating can be
effective since the use of a significantly smaller electrode on
the tumour can effectively steer the power towards the
surface. Therapeutic temperatures can indeed be realised as
demonstrated in a previous simulation study [27]. However,
also in this study radiative heating performed substantially
better as T90 was 0.4–1.1 C higher than with capaci-
tive heating.
Thus, therapeutic temperatures can be achieved with cap-
acitive heating for some patient categories, but clinical stud-
ies have shown that tumour control is correlated to the
target temperatures, and especially the minimum tempera-
ture is predictive for clinical outcome [53,79–81]. For temper-
atures below 42.5 C, as usually reported during clinical
hyperthermia, an increase of 0.5 C already yields a doubling
of the thermal dose, i.e. the cumulative equivalent minutes
at 43 C (CEM43) [82]. This makes it important to aim for the
highest possible tumour temperature and carefully select the
heating equipment for specific patient categories. Treatment
planning can be helpful to qualitatively compare the heating
effectiveness in order to make a well-considered decision on
heating equipment.
Conclusion
This simulation study showed that therapeutic temperatures
are predicted for capacitive heating in patients with (almost)
no fat. Nevertheless, radiative hyperthermia generally yields
much more favourable heating patterns for deep-seated pel-
vic tumours, compared with capacitive heating. With radia-
tive heating higher tumour temperatures are predicted
before treatment limiting hot spots occur, which will benefit
clinical outcome.
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